Pittsburgh Jury’s Attempt to Award $22 Million in Johnson & Johnson Talc Case Highlights Trial Complexities

Start
On Jan. 6, a Pittsburgh jury concluded a month-and-a-half long trial involving a suit asserting that decedent Michaeleen Lee developed mesothelioma from exposure to asbestos-containing talcum powder products made by Johnson & Johnson. The jury found that Johnson & Johnson was negligent in misrepresenting the safety of its talcum powder products….
By: Goldberg Segalla
Previous Story

Health Care Week in Review: CMS Releases Advance Notice of MA and Part D Payment Methodologies and Senate Finance Chair Identifies Key Priorities

Next Story

FDA Publishes Guidance on Medical Device Shortages During Public Health Emergencies